Home > National Drug Code (NDC) > Lithium Carbonate

Lithium Carbonate - 43063-196-60 - (Lithium Carbonate)

Alphabetical Index


Drug Information of Lithium Carbonate

Product NDC: 43063-196
Proprietary Name: Lithium Carbonate
Non Proprietary Name: Lithium Carbonate
Active Ingredient(s): 300    mg/1 & nbsp;   Lithium Carbonate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Lithium Carbonate

Product NDC: 43063-196
Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076243
Marketing Category: ANDA
Start Marketing Date: 20030301

Package Information of Lithium Carbonate

Package NDC: 43063-196-60
Package Description: 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-196-60)

NDC Information of Lithium Carbonate

NDC Code 43063-196-60
Proprietary Name Lithium Carbonate
Package Description 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-196-60)
Product NDC 43063-196
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lithium Carbonate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20030301
Marketing Category Name ANDA
Labeler Name PD-Rx Pharmaceuticals, Inc.
Substance Name LITHIUM CARBONATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Mood Stabilizer [EPC]

Complete Information of Lithium Carbonate


General Information